跳至主要内容
临床试验/IRCT20230913059422N1
IRCT20230913059422N1招募中3 期

Evaluation of the effect of coincident supplementation of vitamin B12, folic acid, and vitamin E on improvement of clinical signs and serum inflammatory markers in patients with Multiple sclerosis

Oroumia University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Relapsing-remitting Multiple Sclerosis (RRMS) according to McDonald's diagnostic criteria
  • EDSS score equal to 6 or less (EDSS = 6)
  • Body mass index (BMI) above 17 and below 30
  • Age between 18 and 65 years
  • Informed consent

排除标准

  • Atrophy of the optic nerve (Leber's disease)
  • Consumption of aminoglycosides, chloramphenicol, colchicine, continuous potassium release products, aminosalicylic acid and its solutions, anticonvulsant drugs and alcohol
  • Taking folate, vitamin B12 and vitamin E supplements up to one year before the start of the study
  • Thyroid disorders

研究者

发起方
Oroumia University of Medical Sciences

相似试验